DEFINITIVE NOTICE AND PROXY STATEMENT

Company

Armata Pharmaceuticals, Inc.

Filed

April 14, 2005

Period of Report

May 26, 2005

Accession Number

0000950124-05-002400

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →